Marcos Lorca

Synthesis, in vitro evaluation and molecular docking of a new class of indolylpropyl benzamidopiperazines as dual AChE and SERT ligands for Alzheimer’s disease

Julio Rodríguez-Lavado, Carlos Gallardo‐Garrido, Michael Mallea et al. · European Journal of Medicinal Chemistry · 2020 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Structure-Activity Relationships Based on 3D-QSAR CoMFA/CoMSIA and Design of Aryloxypropanol-Amine Agonists with Selectivity for the Human β3-Adrenergic Receptor and Anti-Obesity and Anti-Diabetic Profiles

Marcos Lorca, Cesar Morales‐Verdejo, David Vásquez et al. · Molecules · 2018 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor

Javier Romero‐Parra, Hery Chung, Ricardo A. Tapia et al. · European Journal of Pharmaceutical Sciences · 2017 · 24 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Three-Dimensional Quantitative Structure-Activity Relationships (3D-QSAR) on a Series of Piperazine-Carboxamides Fatty Acid Amide Hydrolase (FAAH) Inhibitors as a Useful Tool for the Design of New Cannabinoid Ligands

Marcos Lorca, Yudisladys Valdes, Hery Chung et al. · International Journal of Molecular Sciences · 2019 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17